prompt_version: stage2f-v6-20260329

group: G3 — 方法論的拡張 (Methodological Expansion)
papers: Kumada 1972 (JACS Communication), Monnereau 2009 (Adv. Synth. Catal.), Molander 2016 (Acc. Chem. Res.), Morken 2016 (JACS Communication)
model_info: claude-opus-4-6

---

[F] Within-Group Comparison

---

## repeated_patterns

**RP-1: Catalytic cycle proposed without direct observation of any Ni intermediate under catalytic conditions**

All four papers propose Ni catalytic cycles without characterizing the operative Ni species.

- Kumada 1972: Ni(0)/Ni(II) cycle from analogy to dipy-Ni and other systems; no intermediate isolated in NiCl₂(dpe) (B-2, B-14).
- Monnereau 2009: Thermally activated species (41.8 ppm ³¹P NMR singlet) of unknown Ni oxidation state; proposed Ni(0)/Ni(II) cycle without spectroscopic validation (B-6, U-2); 25% activity of ligand-free Ni unexplained (B-9, U-4).
- Molander 2016: Ni⁰/NiI/NiII/NiIII cycle proposed with no EPR, UV-Vis, or Stern-Volmer data for any intermediate (SRG-1: B-1, U-1, U-2, U-3); control experiments asserted but not shown.
- Morken 2016: pyboxNi(Ar) species proposed as reacting agent with no spectroscopic, kinetic, or stoichiometric evidence; Ni oxidation state unspecified (B-3, U-4, B-18, B-19).

```
evidence_chain: Kumada_1972 : B-2, B-14 ; Monnereau_2009 : B-6, U-2 ; Molander_2016 : B-1, U-1, U-2 ; Morken_2016 : B-3, U-4
```

**RP-2: Analytical foundation for quantitative claims undercharacterized**

All four papers report yield or conversion data whose analytical methods lack complete specification.

- Kumada 1972: glpc conditions absent; yield basis inconsistent between Examples (B-4, B-12, B-13).
- Monnereau 2009: GC response factors unreported for 17 structurally diverse biaryls; no replicates; single-timepoint TOF without kinetic linearity verification (B-1, B-2, B-3, SRG-4).
- Molander 2016: Isolated yields without replicates or uncertainty across all scope tables; HPLC conditions for ee absent; CV conditions for oxidation potentials absent (B-9, B-10, B-11).
- Morken 2016: SFC method unspecified for 17 er determinations; individual run values absent; uncertainty ranges not given (B-6, B-7, SRG-5).

```
evidence_chain: Kumada_1972 : B-4, B-12, B-13 ; Monnereau_2009 : B-1, B-2, B-3 ; Molander_2016 : B-9, B-10, B-11 ; Morken_2016 : B-6, B-7
```

**RP-3: Performance claims asserted without substrate-matched comparison to prior art**

- Kumada 1972: Tamura-Kochi Fe/Cu and Corriu/Masse cited without yield comparison (C-1, C-3).
- Monnereau 2009: "Outperforms fastest diphosphine catalysts" based on single dppp comparison at one substrate/condition; dppb/dppf/DPEphos not tested (B-5, C-1, C-2).
- Molander 2016: Prior Pd-catalyzed methods (refs 7a–f) cited with specific conditions but no common-substrate yield comparison (C-1); Labadie/Stille rate hierarchy cited but not experimentally verified (C-2).
- Morken 2016: Five competing groups (Fu, Zhong/Bian, Nakamura, Breit, Carretero/Jarvo) cited without quantitative performance comparison (C-1, C-2).

```
evidence_chain: Kumada_1972 : C-1, C-3 ; Monnereau_2009 : B-5, C-1, C-2 ; Molander_2016 : C-1, C-2 ; Morken_2016 : C-1, C-2
```

**RP-4: Negative experimental results used as positive mechanistic evidence without quantitative controls**

- Kumada 1972: Absence of R–R byproduct data cited to support "selective" label (B-1, U-1).
- Monnereau 2009: <3% homocoupling stated without scope-wide verification; mercury-drop test absent (B-4, U-4).
- Molander 2016: No radical clock or Stern-Volmer experiment; mechanism inferred from DFT and competition experiment only (U-3, U-6).
- Morken 2016: Radical clock negative result with 44% unaccounted mass balance used to exclude radical pathway (B-1, U-1); stereospecificity experiment based on untested RE retention assumption (B-2, U-3).

```
evidence_chain: Kumada_1972 : B-1, U-1 ; Monnereau_2009 : B-4, U-4 ; Molander_2016 : U-3 ; Morken_2016 : B-1, U-1, B-2, U-3
```

**RP-5: Scope failures described qualitatively without data or diagnosis**

- Kumada 1972: "Only Csp² halides can be used" without stating whether sp³ was tested (B-5).
- Monnereau 2009: Bromomesitylene gives 15.6% conversion vs ~95% for analogous substrates; no attribution (B-12).
- Molander 2016: Amine-containing silicates fail in alkenylation without causal attribution (B-4).
- Morken 2016: ortho-ArMgBr, alkyl/alkenyl-MgX, and heteroatom-bearing substrates all fail without yield/er data or mechanistic diagnosis (B-4, B-5, B-14, SRG-4).

```
evidence_chain: Kumada_1972 : B-5 ; Monnereau_2009 : B-12 ; Molander_2016 : B-4 ; Morken_2016 : B-4, B-5
```

---

## temperature_patterns

```
temperature_pattern: RP-1 (mechanism without intermediate characterization) | papers: [Kumada_1972, Monnereau_2009, Molander_2016, Morken_2016] | profile_consistency: consistent | note: Kumada_1972 B-2 V2=critical; Monnereau_2009 B-6 V2=critical, U-2 V2=critical; Molander_2016 U-2 V2=high; Morken_2016 B-3 V2=high. The V2 (mechanistic) severity remains at the highest levels across all four papers. The specific Ni oxidation state manifold in question changes (Ni(0)/Ni(II) in 1972/2009; Ni(0)/NiI/NiII/NiIII in Molander 2016; unspecified in Morken 2016), but the pattern of proposing specific catalytic cycles without characterizing intermediates is invariant.
```

```
temperature_pattern: RP-2 (analytical undercharacterization) | papers: [Kumada_1972, Monnereau_2009, Molander_2016, Morken_2016] | profile_consistency: consistent | note: V3 severity is high across all papers: Kumada_1972 B-4 V3=medium; Monnereau_2009 B-1/B-2/B-3 all V3=high; Molander_2016 B-9/B-10 single-agent; Morken_2016 B-6 single-agent. The specific analytical method changes (GC/glpc → GC → HPLC/CV → SFC) but the pattern of reporting quantitative values without complete method specification persists unchanged across 44 years.
```

```
temperature_pattern: RP-4 (negative results as positive evidence) | papers: [Kumada_1972, Monnereau_2009, Molander_2016, Morken_2016] | profile_consistency: divergent | note: The severity of this gap increases over time: Kumada_1972's absent byproduct data was rated V1=V2=V3=high (3/3 convergence), reflecting a 1972 norm violation. By Morken_2016, the radical clock's 44% missing mass balance reaches convergence 3/3 (all high) — a more acute version of the same pattern despite 44 years of analytical advancement. Molander_2016 exhibits the pattern in a qualitatively different form: the absence of radical probes in a paper proposing a radical mechanism (U-3, V2=V3=high, 2/3 convergence). The gap is becoming more severe despite improved experimental capabilities.
```

---

## recurring_roots

```
recurring_root: Ni intermediate characterization absent from all mechanistic proposals | papers: [Kumada_1972, Monnereau_2009, Molander_2016, Morken_2016] | member_items: Kumada_1972: SRG-1 (B-2, B-14, U-1, U-2, U-4); Monnereau_2009: SRG-1 (B-6, B-7, U-1, U-2), SRG-5 (U-2, U-4, B-9); Molander_2016: SRG-1 (B-1, U-1, U-2, U-3, U-6, U-8); Morken_2016: SRG-3 (B-3, U-4, B-18, B-19) | note: Structural gap with an individually-chosen component. The structural component: full catalytic cycle validation requires specialized techniques (low-T NMR, EPR, transient absorption spectroscopy) beyond the typical synthetic chemistry toolkit. The individually-chosen component: each paper proposes a "complete" or "plausible" cycle without acknowledging the gap between proposal and evidence as a limitation. The 2016 papers (Molander, Morken) have access to tools unavailable in 1972/2009, making the residual gap increasingly individually chosen.
```

```
recurring_root: Quantitative claims built on single-measurement, unreplicated analytical data | papers: [Kumada_1972, Monnereau_2009, Molander_2016, Morken_2016] | member_items: Kumada_1972: SRG-3 (B-4, B-8, B-9, B-12, B-13); Monnereau_2009: SRG-4 (B-1, B-2, B-3, B-4); Molander_2016: SRG-5 (B-3, B-11), SRG-6 (B-9, B-10); Morken_2016: SRG-5 (B-6, B-7) | note: Genre convention — the reporting norms for synthetic methodology papers across JACS, Adv. Synth. Catal., and Acc. Chem. Res. do not require replicate measurements, uncertainty estimates, or complete analytical method specification. This is a field-wide convention that has persisted unchanged from 1972 to 2016.
```

```
recurring_root: Scope failures undiagnosed and unquantified | papers: [Kumada_1972, Monnereau_2009, Molander_2016, Morken_2016] | member_items: Kumada_1972: B-5; Monnereau_2009: B-12; Molander_2016: B-4; Morken_2016: SRG-4 (B-4, B-5, B-14, A-1) | note: Individually chosen — diagnostic experiments (Hammett studies, competition experiments, systematic steric variation) are straightforward. The convention of reporting only successful substrates and describing failures qualitatively serves the narrative structure of synthetic methodology papers but impedes rational catalyst design.
```

---

## suppression_diagnostic

| Pattern | Diagnostic | Reasoning |
|---------|-----------|-----------|
| RP-1 (Ni intermediates uncharacterized) | Structurally suppressed → individually chosen (evolving) | In 1972, the relevant spectroscopic tools were limited. By 2016, EPR, in situ IR, low-T NMR, and XANES are routinely applied to Ni catalysis. The gap persists because synthetic methodology papers are not expected to contain full mechanistic validation — but the rhetorical framing of mechanisms as "established" or "plausible" exceeds the evidence, making the framing individually chosen. |
| RP-2 (analytical undercharacterization) | Genre convention | Journal norms across all four publications tolerate single-point measurements without replication or complete method specification. No paper deviates from its era's conventions. |
| RP-3 (benchmark absence) | Individually chosen | Quantitative comparison to prior art is always technically feasible; the persistent omission is strategic positioning rather than experimental limitation. |
| RP-4 (negative results as positive evidence) | Individually chosen | Proper controls (mass balance, detection limits, rate-window analysis) are standard analytical practice in all four eras. The choice to use negative results without these controls reflects the synthetic community's tolerance for mechanistic plausibility over proof. |
| RP-5 (scope failures undiagnosed) | Individually chosen | Diagnostic experiments are straightforward but are systematically excluded from scope-focused papers. The convention protects the narrative of "broad scope" by minimizing attention to failures. |

---

## paradigm_competition

This group reveals **paradigm competition** between three distinct catalyst design philosophies for extending Kumada-type cross-coupling:

**Paradigm A: Ligand engineering (Kumada 1972, Monnereau 2009)**
- Strategy: Optimize the diphosphine ligand (bite angle, steric bulk, electronic properties) within a classical Ni(0)/Ni(II) framework.
- Systematically unanswered: [REDACTED: substantial verbatim quotation; see Tier 9] Kumada 1972 presents a qualitative activity order (B-3); Monnereau 2009 proposes a dynamic bite-angle effect without kinetic validation (U-3) or rigid-backbone control (A-2).
```
evidence_chain: Kumada_1972 : B-3 ("cis configuration... first requisite"), U-4 (equivocal attribution); Monnereau_2009 : A-2 ("non-dynamic versions... would be very useful"), U-3 (RE vs OA rate-limiting step tension)
```

**Paradigm B: Activation mode switching (Molander 2016)**
- Strategy: Replace two-electron transmetalation with single-electron radical generation via photoredox, enabling sp³ substrates.
- Systematically unanswered: [REDACTED: substantial verbatim quotation; see Tier 9] No Stern-Volmer, EPR, or quantum yield data reported (SRG-1).
```
evidence_chain: Molander_2016 : U-1 (dominant quencher unknown), U-2 (Ni oxidation states unassigned), U-7 (DFT model system not transferable)
```

**Paradigm C: Substrate design for enantioselection (Morken 2016)**
- Strategy: Engineer the electrophilic substrate (prochiral cyclic sulfate) to enable desymmetrization via chiral Ni catalysis.
- Systematically unanswered: [REDACTED: substantial verbatim quotation; see Tier 9] Neither Eyring analysis nor competition experiments reported (U-2, B-18).
```
evidence_chain: Morken_2016 : U-2 (kinetic vs thermodynamic control untested), B-18 (er variation across ArMgBr used as sole evidence for reactive species identity), B-2 (RE retention assumed)
```

The three paradigms are genuinely competitive: each offers a different answer to "how to extend Kumada coupling beyond its original scope." They are not sequential — all three coexist as of 2016, addressing different facets of the same limitation (substrate generality). Each paradigm's blind spot is different from the others', and no single paradigm addresses all three unanswered questions simultaneously.

---

## divergences

**DV-1: Activation mode — thermal (1972/2009/Morken 2016) vs. photoredox (Molander 2016)**

Kumada 1972, Monnereau 2009, and Morken 2016 all use thermal activation (Grignard + Ni catalyst at controlled temperature). Molander 2016 uses photochemical activation (visible light + Ir/Ru photocatalyst + Ni co-catalyst). This is the most fundamental divergence in the group.

```
evidence_chain: Kumada_1972 : S0-4 ("Grignard reagent with an organic halide"); Molander_2016 : S0-1 ("photoredox/nickel dual catalysis")
```

Accounts for divergence: Paradigm shift — Molander's photoredox approach represents a conceptually distinct solution to the sp³ transmetalation problem, operating through radical intermediates rather than polar organometallic species.

**DV-2: Selectivity goal — yield optimization (1972/2009) vs. enantiocontrol (Morken 2016) vs. paradigm demonstration (Molander 2016)**

Each paper optimizes for a different selectivity axis: Kumada 1972 for cross/homo selectivity and scope; Monnereau 2009 for TOF; Morken 2016 for enantioselectivity; Molander 2016 for conceptual proof-of-principle.

```
evidence_chain: Kumada_1972 : D-1 ("selective cross-coupling"); Monnereau_2009 : D-1 (TOF up to 21250); Morken_2016 : D-1 (er 96:4); Molander_2016 : D-1 ("new paradigm for sp³–sp² cross-coupling")
```

Accounts for divergence: Subfield maturation — the original Kumada coupling (1972) needed to demonstrate feasibility; by 2009/2016, the field had diversified into specialized optimization axes.

**DV-3: Electrophile class — aryl halides (1972/2009) vs. aryl halides + alkenyl halides (Molander 2016) vs. cyclic sulfates (Morken 2016)**

```
evidence_chain: Kumada_1972 : B-5 ("Only Csp² halides"); Molander_2016 : S0-1 ("aryl and alkenyl halides"); Morken_2016 : S0-1 ("symmetric cyclic sulfates")
```

Accounts for divergence: Substrate innovation — cyclic sulfates as electrophiles (Morken 2016) represent a fundamentally new substrate class for Kumada-type coupling, while Molander retains conventional halide electrophiles but changes the nucleophilic partner.

---

## recurring_U

```
recurring_U: Self-contradictory absence — proposed mechanisms predict testable outcomes that the paper does not test | papers: [Kumada_1972, Monnereau_2009, Molander_2016, Morken_2016] | item_ids: [Kumada_1972: U-1, U-2; Monnereau_2009: U-1, U-2, U-3; Molander_2016: U-1, U-2, U-3, U-6; Morken_2016: U-1, U-3, U-4] | note: Every paper in this group contains U-items classified as "self-contradictory absence" — where the paper's own proposed mechanism predicts specific observable outcomes that go untested. Kumada_1972: eq 3 predicts R–R but it is unreported. Monnereau_2009: TOF denominator contradicted by incomplete activation; proposed cycle predicts Ni(0) but oxidation state is unassigned. Molander_2016: cycle predicts Stern-Volmer-detectable quenching and EPR-observable Ni(I)/Ni(III); neither tested. Morken_2016: cycle predicts observable Ni intermediates and SN2-like OA predicts invertive stereochemistry, but RE retention is assumed without test. The persistence of this U-pattern across four independent research groups suggests it reflects a structural feature of synthetic methodology publication: the cycle diagram is the expected deliverable, but its testable predictions are not part of the expected evidence set.
```

---

## group_unasked_question

[REDACTED: substantial verbatim quotation; see Tier 9]

```
evidence_chain: Kumada_1972 : B-2 (Ni(0)/Ni(II) unvalidated), U-2 (black mixture suggests heterogeneous Ni); Monnereau_2009 : U-2 (41.8 ppm Ni species unidentified), U-4 (homogeneous vs heterogeneous untested); Molander_2016 : U-2 (NiI/NiIII unassigned), U-1 (quenching identity unknown); Morken_2016 : B-3 (Ni oxidation state unspecified), U-4 (no intermediate characterized)
```

TEMPERATURE_SUMMARY correspondence: The group-level question corresponds to the highest-severity items across all four papers: Monnereau_2009 U-2 (V2=critical, single agent) and B-7 (convergence 3/3, V3=critical); Morken_2016 B-1 (convergence 3/3, all high) and B-2 (convergence 3/3, V2=critical); Molander_2016 U-7 (convergence 3/3, all high). All concern the gap between proposed Ni species and their experimental evidence.

recurring_root correspondence: The group-level question directly reflects the first recurring root ("Ni intermediate characterization absent from all mechanistic proposals"). The question asks what all four papers' mechanisms predict but do not test: the identity of the active species. The group's diversity — spanning thermal/photoredox/chiral variants of Kumada coupling — makes this question especially diagnostic: if the same Ni species operates across all variants, the unifying principle is the metal; if different species operate, the unifying principle is the substrate-catalyst interaction geometry. Neither answer can be obtained without intermediate characterization.

---

> **Tier 8 redaction notice**: This file is a redacted copy of the corresponding Tier 3 / Tier 9 output. Verbatim source-paper quotations have been replaced by `[REDACTED: see source paper §<loc>; full text retained in Tier 9 reviewer-only deposit]` markers, preserving location references and our own analytical content. Bibliographic fields (title, authors, journal, year, DOI), analytical labels (`evidence_chain:` with B-/U-/A-/C- internal IDs), short technical terms, and our own analytical text are not redacted. The redaction was applied by `scripts/redact_for_tier8.py` and, for this version, by `scripts/build_paperA_R1_public.py` with `scripts/redact_source_ngram_runs.py` (scripts of the project repository; they are not deposited).
